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Summary
We identified, in independently generated hybridoma antibodies, blocks of shared somatic alterations
comprising four consecutive amino acid replacements in the CDR2s of their heavy chain variable
regions. We found that the nucleotide sequences encoding the shared replacements differed slightly.
In addition, we performed genomic cloning and sequencing analyses that indicate that no genomic
sequence could encode the block of shared replacements in any one of the antibodies and thus
directly serve as a donor by a recombinational process. Finally, in a survey of other somatically
mutated versions of the same heavy chain variable gene, we found several examples containing
one, two, or three of the shared CDR2 mutations in various combinations. We conclude that
the shared somatic alterations were acquired by several independent events. This result, and the
fact that the antibodies containing the four shared mutations were elicited in response to the
same antigen and are encoded by the same V and VK gene segments, suggests that an intense
selection pressure has fixed the shared replacements by favoring the clonal expansion of B cells
producing antibodies that contain them. The basis ofthis selection pressure is addressed elsewhere
(Parhami-Seren, B., L. J. Wysocki, M. N. Margolies, and J. Sharon, manuscript submitted for
publication) .
A
n important but poorly understood process termed "so-
matic mutation" introduces sequence alterations in an-
tibody V genes expressed by members of the B lymphocytic
lineage (1-7). In the absence of an identified mechanism, so-
matic mutations are operationally defined as sequence differ-
ences between an expressed V gene and the corresponding
germline V gene from which it was derived. In practice, so-
matic mutations are identified by sequences of V genes ex-
pressed by B cells that are immortalized by cell fusion with
myeloma cell lines (reviewed in reference 8). This hybridoma
approach allows one to estimate both the timing ofthe muta-
tional process and the rate at which it occurs. Results of such
studies have shown that V gene-specific somatic alterations
are acquired at a high rate (9-11) (10-a to 10-s/bp per gener-
ation) during the antigen-driven stages of B cell differentia-
tion (11-18). These observations support the idea that so-
matic mutations are introduced by a differentiative process
rather than simply being the accumulated products of spon-
taneous events.
The influence of selection on mutated V regions has been
documented structurally by the high ratio of replacement to
silent mutations in CDRs as opposed to framework regions
(9, 19), and by the reproducible isolation of independently
derived hybridomas producing antibodies with identical amino
acid replacements (12, 20-23). Theseresults are complemented
by others demonstrating that a positive selection pressure favors
the clonal expansion of B cells expressing mutant antibody
V regions with increased affinity for the eliciting antigen rel-
ative to that of the germ-line antibody (12, 16, 20, 24-27).
Here, we identify two independently generated hybridomas
producing antip-azophenylarsonate (Ars)l antibodies that
are encoded by mutated versions of the same germline V
gene segment and that remarkably share four consecutive iden-
tical amino acid replacements within a stretch of eight amino
acids in the second CDR. The shared mutations are not the
' Abbreviations used in this paper: ARS, p-azophenylarsonate; TMACI,
tetramethyammonium chloride.
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by a recombinational (gene conversion) mechanism, as re-
vealed by genomicsearching andnucleotide sequencing anal-
yses. We conclude that the shared mutations are acquired by
multiple independent events and are fixed by an intense se-
lection pressure that favors the clonal expansion of B cells
expressing the mutant V region products.
Materials and Methods
Cell Lines.
￿
Hybridomas 45-49 (28) and 91A3 (29) were pre-
paredfrom splenocytes ofA/J mice immunized with protein con-
jugatesof Ars. Theantibodies produced by thesehybridomas bind
Ars and are encoded by the V gene segment (V IdcR) that en-
codes V regions bearing the major cross-reactive idiotype (CRIA
or IdcR) associated with strain A anti-Ars antibodies (30). Hy-
bridoma 91A3 was provided by Dr. J. Donald Capra (University
of Texas Health Science Center, Dallas, TX).
Preparation of Peptides and Amino Acid Sequence Analyses of
45-49. The A/J anti-Ars hybridoma protein 45-49 (y 1, u) was
amplified in the ascites of CAM mice (The Jackson Laboratory,
Bar Harbor, ME) and purified by affinity chromatography (28).
Partial NHZ-terminal sequences for the 45-49 H (48 cycles) and
L (42 cycles) chains were reported previously (28). The sequence
oftheL chainwas completed usingpeptides produced by cleavage
with o-iodosobenzoic acid and with trypsin, resulting in the
identification ofallresidues spanning positions35-75, 62-96, and
97-108. The complete sequence of theHchainwas obtained largely
using tryptic peptides derived from the citraconylated chains and
from tryptic daughter peptides obtained after partial or complete
decitraconylation. Methods for the partial reduction and alkyla-
tion of purified antibodies, chainseparation, preparation of tryptic
peptides from citraconylated, completely reduced and alkylated
chains, preparation of CNBr peptides, and purification ofpeptides
by gel filtration and HPLC were performed as described (31-34).
Automated Edman degradation was carried out using either a se-
quencer (890C; Beckman Instruments, Inc., Fullerton, CA) or a
gasphase sequencer (470A; Applied Biosystems, Inc., Foster City,
CA) as described(34). Selective sequence ofprolyl-containing pep-
tides contained in mixtures wasperformedusingo-phthalaldehyde
treatment (35). Phenylthiohydantoin amino acids were identified
by HPLC.
Probes. A 24-base oligonucleotide (GTGAATATAACCTTTTC-
CAGGATG) wassynthesized andprovidedby Dr. K.L. Ramachan-
dran of Biogen Research Corp., Cambridge, MA. This sequence
is complementary to thecoding strand spanning codons 52-59(con-
secutive numbering system) in the CDR2 of the V region of
45-49 (see Fig. 1). The 5' and 3' nucleotides of this probe define
the somatically alteredboundaries encoding theregion containing
thefour amino acid replacements (somatic mutations) that are shared
with 91A3.Asimilaroligonucleotide (ATGAATgTAACCTTTTC-
CAGGATG) defining the corresponding region of theV IdcR gene
expressedby 91A3 (36) was synthesized by theMolecular Resource
Center at theNational Jewish Center forImmunology andRespi-
ratory Medicine. This sequence differs at two positions (under-
lined) from the 24merof45-49. Forusein hybridization analyses,
these oligonucleotides were labeled to a sp act of 1-1.3 x 109
cpm/Fig with asp using T4 polynucleotide kinase (37).
Southern Blots.
￿
Cellular andgenomicDNAs were digested with
EcoRI (20 jig DNA, 50 U enzyme), run on 0.75% agarose gels,
and transferred to nitrocellulose in 20x SSC (1 x SSC is 150 mM
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NaCl, 15 mM sodium citrate, pH 7) (38) or to Nylon (Gene Screen
plus; New England Nuclear, Boston, MA) in 0.4 N NaOH (39).
Hybridizations were done at 45°C in 10 ml of asolution containing
60 ng (6-8 x 101 cpm) of end-labeled probe, bx SSC, 10% dex-
tran sulfate, 5x Denhardt's solution (1 x is 0.02% [wt/vol] BSA,
polyvinyl pyrrolidone, and ficoll [M = 400,000]), 500 F.g/ml
ssDNA, 1% SDS, 25 mM Tris, pH 7.5, and20 mM EDTA. Figure
legends indicate specific departures from this general protocol and
give details concerning washingconditions, lengths of hybridiza-
tions, and film exposures. Phage DNAs were handled similarly,
except that theamount of digested DNA loaded per lane was less
(25 ng).
Cloning Genomic Sequences. A/J kidney DNA was partially
digested with Mbol and run on a 0.6% agarose gel. Fragments
with an average length of 16 kb were electroeluted into dialysis
tubing, purified using an Elutip column (Schleicher & Schnell, Inc.,
Keene, NH), and ligated to the left and right "arms" of phage A
cloning vector EMBL4 (40) (Promega Biotech, Madison, WI) that
hadbeen digested with BamHI and Sall. Ligation products were
encapsidated (41) usinga commercially availablepackagingextract
(Gigapack; Stratagene, La Jolla, CA), and unamplified phage were
plated on the Escherichia coli strain NM539. Resulting recombinant
phage plaques (1.5 x 106) were lifted onto nitrocellulose filters (42)
in duplicate and hybridized with a "P-labeled 24-base probe (en-
coding the shared somatic mutations in the CDR2 of antibody
45-49) for 16 h at 45°C in the following solution: 6x SSC, 5x
Denhardt's solution, 100 Irg/ml ssDNA, and0.5% SDS. Thefilters
were washed at 50°C in a solution of 6x SSC and 0.5% SDS.
X-ray film (Kodak XAR-5) was exposed to the washed filters at
-70°Covernight with an intensifying screen. Plaques giving posi-
tive hybridization signalswere picked andisolated by threerounds
of subcloning and screening under the same conditions.
To identify the recombinant phage harboring inserts with se-
quences most related to the 24mers of 45-49 and 91A3, washes
at increasing temperatures were performed in a solution of 3 M
tetramethylammonium chloride, 25 mM Tris (pH 8.0), 20 mM
EDTA, and 0.5% SDS, as described(43). In this buffer, the differ-
ence in meltingtemperatures of AT vs. G-C by is eliminated (44).
Nucleic Acid Sequencing.
￿
A 5.5-kb EcoRl fragment containing
the VIdcR gene expressedby 45-49 was provided by Dr. Thomas
Gridley (Roche Institute, Nutley, NJ). From this, a 380-bp Pstl
fragment containing the first 92 codons of the VIdcR and 5'
flanking sequence was subcloned into plasmidpGEM 4 (Promega
Biotech) and sequencedin both directions using T7 andSP6 primers
in a dideoxy chain termination procedure (45), according to the
manufacturer's (Promega Biotech) instructions. Total RNA was
isolated from 45-49 and 91A3 by the method of Chirgwin et al.
(46). VIdcR mRNA was sequenced from each of these hybrid-
omas using a universal IgG primer and reverse transcriptase as de-
scribed (47).
GenomicDNAfragmentscontaining sequences that hybridized
to the 24-baseprobewere subcloned into phagemid M13 KS+/-
(Stratagene), isolated as single-strandedcircles aftersuperinfection
with helper phage R408 (Stratagene), as described (48), and se-
quencedusingtheM13reverseand T7 primers (45). In all, 14 recom-
binant fragmentswere subclonedandsequenced:the sixclones with
sequences most identical to the 24mer of 45-49 were subcloned
as 297-bp TagI-Sau3AI fragments; four ofthe clones that were de-
termined to be second most identical to the24mer of 45-49were
subcloned as 144-bp Sau3A fragments; twoclones with sequences
most identical to the24merof91A3 were subcloned as 190-bp Sau3A
fragments; and two clones with sequences second most identical
to the 24mer of 91A3 were subcloned as 210-bp HaeIII fragments.A
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Figure 1.
￿
Sequences of the V and Vk regions of 45-49 and 91A3. Shown are the amino acid and the nucleotide sequences encoding (A) the
H chain and (B) L chain V regions of anti-Ars hybridoma antibodies 91A3 and 45-49 compared with the corresponding germline sequences that
are represented by antibody 36-65. The vertical bars in the V regions delineate the region containing the four consecutive shared amino acid
replacements (somatic alterations). Lines indicate identity with the top (germline) sequence. Gaps indicated by a period are introduced to maximize
homology. Codons are numbered consecutively, and the one letter code is used to designate amino acids (63).
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Consecutive Shared Mutations in Independently Isolated Anti-
body V Regions. The hybridomas under consideration are
designated 45-49 and 91A3 (28, 29). They were produced
in fusions of splenic lymphocytes from strain A/J mice that
were immunized with Ars conjugates ofcarrier proteins, and
both secrete antibodies that bind Ars.
The two hybridomas are ofindependent origin: 45-49 was
produced by Ann Marshak-Rothstein at the Massachusetts
Institute of Technology (28), and 91A3 was produced at
Brandeis University by Estess et al. (29) . The antibodies they
produce were a topic of interest in earlier studies, when it
was observed by NH2-terminal sequencing analyses that they
appeared to be encoded by the same VH (VIdCR) and Vk
(VkIdCR) gene segments that encode the predominant popu-
lation of A/J antiArs antibodies, even though both lacked
the associated idiotype called CRIA or IdcR (28, 33, 49).
This supposition was confirmed by Southern blotting anal-
yses using VIdcR and VkldcR probes (data not shown) and
by the complete amino acid sequences reported here for 45-49,
and previously (50) for 91A3 (Fig. 1) .
One ofus (M.N. Margolies) determinedthe complete amino
acid sequences ofthe H and L chain V regions of 45-49 (see
Materials and Methods), compared them with the published
sequences for 91A3 (50) and to the corresponding germline
sequences (51-53), and observed that both shared four con-
secutive identical amino acid replacements (somatic muta-
tions) in CDR2 of their H chains.
The H and L chain V sequences, aligned with respect to
the corresponding germline sequences ofantibody 36-65, are
shown in Fig. 1. The sequences reveal that both antibodies
are encoded by the same V gene segments that encode the
predominant antiArs IdCR+ antibodies, with the exception
of the D region, and both are heavily mutated. Antibody
45-49, in particular, is hypermutated: it contains 13 amino
acid replacements in the H chain V region and four in the
L chain V region. Outside of the shared set of four amino
acid replacements in the H chain CDR2s, however, the anti-
bodies share no other mutations.
Nucleotide Sequences Distinguish Regions with Shared Amino
Acid Replacements. We sequenced the cloned VIdcR gene
expressed by 45-49 and compared it to the published nucleo-
tide sequence of the VIdcR gene expressed by 91A3 (36)
and to the sequence of the germline VIdCR gene segment
(51) . These comparisons are shown in Fig. 1 and reveal that:
(a) the 45-49 VH gene contains 20 nucleotide substitutions
(somatic mutations); (b) the two VHIdCR genes share no
other nucleotide substitutions outside of the region ofshared
amino acid replacements, and, most important; (c) in the re-
gion of shared amino acid replacements, the two genes differ
in sequence by two nucleotides, one of which is a silent sub-
stitution in the third position of the tyrosine 57 codon, and
the other is in the third position of the histidine 59 codon.
The importance of the nucleotide sequence differences in
the regions of shared amino acid replacements prompted us
to confirm both sequences. We obtained from J.D. Capra
(University ofTexas Health Science Center, Dallas, TX) the
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91A3 hybridoma, prepared RNA from it and from 45-49,
and sequenced both VHIdcR mRNAs by using reverse tran-
scriptase primed with a C region oligonucleotide in the dide-
oxynucleotide chain termination procedure (47). Both se-
quences were confirmed.
Isolation from the Genome of Potential Donor Sequences for
the Shared Mutations. The differences in nucleotide sequence
between 45-49 and 91A3 in the region of shared amino acid
replacements is most consistent with a model in which point
mutations followed by intense selection for particular amino
acid replacements resulted in the parallel fixation of the four
shared somatic alterations in the CDR2s of 45-49 and 91A3.
This conclusion seemed surprising, particularly in view of
the fact that the shared blocks offour replacements were the
only somatic alterations that were shared by the two VIdcR
genes: the changes suggested to us that they might have been
introduced from the genome by recombinations involving
cassettes of sequence information. In principle, the nucleo-
tide sequence disparities could be accounted for by recombi-
nations involving two different but related germline donors
belonging to a family. We were therefore prompted to pro-
vide more conclusive evidence for one model or the other.
To this end, we prepared a total genomic library of A/J
DNA and screened it for potential donor sequences (for the
shared somatic alterations) using a 24-base probederived from
the CDR2 of 45-49. The 5' and 3' nucleotides of the 24-
base probe were defined by the first and last nucleotide sub-
stitutions (mutations) in the region of shared amino acid
replacements (see Materials and Methods) . We ligated Mbol
fragments with an average length of 16 kb from partially
digested A/J kidney DNA to the arms ofthe phage X vector
EMBL4 (40). 1.5 x 106 recombinant phage containing ap-
proximately eight genomic equivalents of A/J DNA were
screened in duplicate. Of 63 primary plaques that were ini-
tially selected, 52 were eventually recovered after three rounds
of subcloning.
The hybridizations and washes in the primary screen and
subcloning screens were uniformly performed undernonstrin-
gent conditions. To identify the genomic clones most iden-
tical in sequence to the 24mer, we subjected filters containing
hybridized DNA from the 52 selected recombinant phage
to a series of washes at increasing temperatures. To ensure
that clones were selected on the basis of sequence identity
and not on the basis of sequence composition (i.e., AT vs.
G-C bp), we performed the washes in a solution containing
3 M tetramethylammonium chloride (TMACI) in which the
melting temperature of AT by is the same as that of GC by
(43, 44). Six recombinant phage were found to harbor in-
serts with sequence information that was most identical to
the probe, as revealed by the signal intensity at the more strin-
gent washing temperatures. At a temperature of 63°C in a
solution of 3 M TMACI, however, all of the hybridization
signal was eliminated while insignificant reduction in the hy-
bridization signal was observed for the positive control, which
was provided by recombinant phage containing the rearranged
VHIdcR gene of 45-49. On the basis of melting temperature,
a second group of six phage were judged to harbor insertsthat were slightly less identical than the first six, but more
so than the remaining 41 . Four of these were selected for
further analyses .
To confirm that we had cloned the genomic sequences most
Figure 3 .
￿
Cloning of potential donor sequences for the shared so-
matic alterations in 91A3 . Southern blotting analyses of EcoRI digests
were done using the 24-base probe derived from the CDR2 of the
VIdck gene encoding 91A3, as described in Materials and Methods.
(A) Blot was hybridized for 3 d, washed nonstringently in 6x SSC, at
a temperature of 45°C, and exposed to film for 3 d. Signal at 5.5 kb
identifies the rearranged and expressed V IdcR gene of 91A3 . (B and
C) Lanes 1-4 contain phage DNAs (Kl-K4) digested with Ecokl that
harbored sequences related to the 24 met of 91A3. The higher temper-
ature wash (C) shows that Kl and K2 contain sequences most iden-
tical to the 24 met of 91A3 (see sequences in Fig. 4 B) .
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Figure 2 .
￿
Cloning of potential donor sequences for
the shared somatic alterations in 45-49. Southern
blots of EcoRl-digested DNAs were performed as
described in the Materials and Methods using the 24-
base probe derived from the CDR2 of the VIdCA
gene encoding 45-49. Hybridization signals at 5 .5 kb,
in A and B identify the rearranged and expressed
VIdcR gene of 45-49 . (A) Blot was hybridized for
3 d, washed nonstringently at a temperature of 55°C
in TMACI buffer, and exposed to film for 3 d . (B)
Blot was hybridized for 3 d, washed more strin-
gently at a temperature of 60°C in TMACI buffer,
and exposed to film for 3 d. (C) Lanes 1-6 contain
EcoRl-digested DNAs from recombinant phage (Hl-
H6) harboring inserts that were judged to be most
identical to the 24 met of 45-49 (see sequences in
Fig. 4) . Lanes 7-10 contain digested phage DNAs
(117-1110) harboring sequences that were slightly less
related to the probe (see sequences in Fig. 4 A) .
identical to the 24mer from 45-49, we performed a genomic
Southern blot with this probe and identified EcoRI fragments
of 4.9 and 4.5 kb in length that were most identical to the
probe because, following a high stringency wash, only signals
at those locations were observed (Fig. 2, A and B) . Phage
DNA from the first six selected clones also produced EcoRI
fragments of4.5 kb inlength that hybridized with the 24mer,
and three of the four selected phage from the second group
produced a signal at 4.9 kb (Fig . 2 C) .
The nucleotide sequence differences between the two
VIdcR genes in the region of shared substitutions were lo-
cated near one end of the block (at relative positions 18 and
24 ; Fig . 1) . This, together with the fact that the genomic
library was screened under nonstringent conditions, suggested
to us that the 52 selectedrecombinant phage that were screened
with the 24mer of 45-49 might also harbor the genomic se-
quences most identical to the corresponding region of 91A3 .
Thus, we screened the selected 52 phage with aDNA probe
of 24 nucleotides that defined the somatically altered region
of interest in 91A3 . Two clones were identified that hybrid-
ized more strongly to the probe than any of the remaining
50 . These two clones produced EcoRI fragments of 5.2 kb
in length that hybridized with the 24mer of 91A3 (Fig. 3,
B and C) . Two other clones were identified that hybridized
with the 24mer less strongly than the first two, but more
so than the remaining 48 . These produced EcoRI fragments
of 3.2 kb that hybridized with the probe. When genomic
DNA was digested with EcoRI and hybridized with the 24mer
of 91A3 under nonstringent conditions, hybridization signals
were seen only at 5 .2 and 3.2 kb (Fig. 3 A) . It thus appeared
that we had also cloned the genomic sequence most identical
to the 24mer of91A3 in our initial genomic search with the
corresponding 24 mer of 45-49 .
No Obvious Genomic Donorsfor the Shared Mutations.
￿
From
the selected phage that harbored the genomic sequences most
identical to the 24-base segments defining the regions of shared
mutations, we subcloned and sequenced short DNA frag-A
Germline
VHIdCR
45-49
￿
: GGA TAT ATT
6 clones (H1-H6) : TCT TGC AGG
4 clones (H7-H10) : CAG CCT TTA
B
Germline
VHIdCR
￿
GGA TAT ATT
91A3
Discussion
GGA TAT ATT
GGA TAT ATT
2 clones (K1, K2) : CTG AAA TTT
2 clones (K3, K4) : CCA CTG AGG
N
￿
N
￿
T K
AAT CCT GGA AAT GGT TAT ACT AAG
H
￿
K
￿
I H
CAT CCT GGA AAA GGT TAT ATT CAC
AC=A GGA AAA GGT TAT ATT CAC
TAZ ACT GGA AAA_ GGT TAT ATT CCT
N
￿
N
￿
T K
AAT CCT GGA AAT GGT TAT ACT AAG
H
￿
K
￿
I H
CAT CCT GGA AAA GGT TAC ATT CAT
CAT CCT GGA AAA GGT TAC GIG ACA
SAT G .T
￿
, .A
￿
aA
￿
, ,A
￿
AC ATT CAC
ments (<300 bp) containing these sequences (see Materials
and Methods). Phage belonging to each selected set produced
fragments with identical sequence. Consistent with the
melting temperature data, we found that none of the frag-
ments contained sequences that were identical to either 24mer.
The closest sequence (cloned independently six times) matched
at 21 :24 nucleotides, including a stretch of 18 continuous
matches with the 45-49 sequence (Fig. 4 A). The nearest
genomic sequence to the 24mer of 91A3 (cloned twice in-
dependently) also matched at 18 continuous positions (Fig.
4 B). We therefore conclude that no genomic sequence could
generate either of the somatically altered regions in 45-49
and 91A3 by a single recombinational event. A minimum
of three different donor sequences involved in two recom-
binational events for each of the two expressed VHIdCR genes
would be necessary to construct the shared blocks of amino
acid replacements.
None ofthe cloned segments demonstrated significant ho-
mology with the VHIdCR gene beyond the 5' and 3' bound-
aries of the probes that were used in the search, and none
was an Ig V gene, as revealed in computer searches of the
Genbank database (release 59.0) rodent files. These two ob-
servations argue that ifrecombinational events played any role
at all in the somatic alteration of the VHIdCR gene segments
encoding the shared amino acid replacements, the sequences
cloned here were probably not involved, even though they
are the genomic sequences most identical to the regions of
shared mutations.
Recombinational mechanisms, including gene conversion,
have undoubtedly contributed on an evolutionary time scale
to the generation of the mammalian germline repertoire of
V gene segments (reviewed in reference 54). A somatic gene
conversion mechanism apparently diversifies the repertoire of
V regions expressed by avian B cells during their ontogeny
in the bursa (55, 56) . A somatic gene conversion-like process
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TAC AAT GAG
Figure 4.
￿
Nucleotide sequences
of cloned genomic segments most
identical to regions encoding so-
matic alterations that are shared by
45-49 and 91A3. Vertical bars
define the V region where 45-49
and 91A3 share four consecutive
somatic alterations. Positions where
the cloned germline segments are
identical in sequence to those of
TAC AAT GAG
￿
45-49 (A) or 91A3 (B) are under-
lined. Sequences are aligned to
maximize identity. Amino acids in
CDR2 that are shared by 45-49
and 91A3 and that differ from
those encoded by the germline V
gene are shown explicitly above the
nucleotide sequences.
TAC AAT GAA
AAT TAT_GGT
ACA GAG AAC
TAT AAT GAG
AAT GAT C
CCA GCT QCA
has been invoked to explain somatic alterations sustained in
antibody V genes expressed by hybridoma cell lines that are
grown in vitro (57, 58) . Evidence in support of such mecha-
nisms as the means by which somatic mutations are intro-
ducedinto mammalian Ig V genes in vivo, however, is lacking.
The first argument against such a mechanism derived from
the finding that specific somatic alterations within V genes
could not be accounted for by the germline sequences of the
nearest V gene relatives. These observations were first made
for V genes (antiphosphorylcholine V genes [6) and V X
genes [59]) belonging to small families, the members ofwhich
were all cloned and sequenced. The argument was thus based
on the assumption that any recombinational event should in-
volve V genes with the greatest degree of homology.
This assumption became questionable when it was real-
ized that somatic alterations are under the influence of selec-
tion pressure(s), one of which favors the clonal expansion
of B cellsexpressing altered V regions with increased affinity
for the immunizing antigen. This selection pressure is re-
vealed in general by the fact that mutated hybridoma V regions
tend to bind antigen with higher affinity than unmutated
V regions (12, 16, 24), and more specifically by experiments
demonstrating that particular somatic alterations that are
reproducibly and independently isolated confer an increased
affinity for the eliciting antigen (25, 26). The influence of
selection, therefore, introduces a bias in hybridoma sampling
procedures, favoring the isolation of hybridomas expressing
V genes containing the somatic alterations that confer upon
the encoded antibody an increase in the affinity for the eliciting
antigen. Thus, more distantly related V genes might be the
donors for the observed somatic alterations via recombina-
tion, provided they introduce altered codons that encode the
structural changes producing affinity increases.
The possibility that more distantly related V genesmight
function as recombinational donors for somatic alterations
was addressed by Chien et al. (60), who searched the genome
for potential donors of somatic alterations byperforming strin-
gent Southern blotting analyses with oligonucleotide probesthat defined segments of somatically altered V genes. They
found no evidence for donors of somatic alterations by this
method. The experiments reported here, which support their
conclusion, carry this type ofanalysis a step further by cloning
from the genome the sequences that are most identical to
somatically altered segments shared by two V genes ex-
pressed by hybridomas of independent origin. Our results
show that no single sequence nor combination of two se-
quences in the A/J genome could serve as the donor(s) for
all of the consecutive shared alterations found in the V
genes expressed by the two hybridomas. The possibility that
the shared alterations were derived from genomic sequence
information contributed by the SP2/0 cell line post-fusion
is also unlikely from three lines of evidence. First, SP2/0 and
A/J DNAs produce identical signal patterns upon hybrid-
ization with the oligonucleotide probes that define the shared
alterations, and both sets of signals disappear with washes
performed at the same level of stringency (Fig. 2 and unpub-
lished results), indicating the absence of additional potential
donor sequences in the SP2/0 DNA. Second, the shared al-
terations confer an increased affinity for the eliciting antigen,
Ars (unpublished results), so their independent acquisition
in vitro, without the apparent benefit of an antigenic selec-
tion pressure, would be a monumental coincidence. Finally,
if somatic alterations were introducedfrom the SP2/0 parent
in vitro, we would expect to observe them regardless of the
timing of the fusion event, which is inconsistent with the
observation that somatic alterations are seen neither in V genes
of hybridomas generated by fusions (with SP2/0) performed
during the early primary immune response to Ars (12), nor
in V genes of hybridomas generated by fusions ofpreimmune
B cells (13).
While this manuscript was in preparation, a third example
of a mutated VIdCR gene containing the four shared CDR2
somatic alterations was reported by Fish et al. (61). Anti-Ars
hybridomas 8AS2A, C, and E (apparently members of a single
lineage) express a VIdCR nucleotide sequence identical to
that of 45-49 in the region of shared CDR2 amino acid
replacements. In the same report are other sequences of ex-
pressed VIdcR genes that contain one, two, or three of the
four alterations shared by 45-49, 91A3, and 8AS2, supporting
the hypothesis that each of the alterations is derived indepen-
dently, perhaps by a point mutation mechanism. Most sup-
portive of this idea are two members of a common lineage,
clones AS13F and AS13B, that, respectively, have two and
three of the shared replacements. Their sequences in this re-
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36-65 (germline)
￿
AAT CCT GGA AAT GGT TAT ACT AAG
45-99
AS13F
AS13B
52
￿
55
￿
58 59
Figure 5.
￿
Stepwise accumulation of shared somatic mutations. Partial
sequences of V genes expressed by 45-49 and two clonally related hy-
bridomas are aligned and compared to the germline sequence of the
same V gene expressed by 36-65. Lines indicate identity with the top
(germfne) sequence. Amino acids are shown above codons that are
influenced by mutations. Sequence data for AS13F and AS13B are taken
from Fish et al. (62).
gion are aligned (Fig. 5) compared with those of 45-49 and
a germline (36-65) clone.
An asparagine to histidine replacement at position 52 is
found in only one of the two clones (8AS13B), and the
asparagine to lysine replacements at position 55 are acquired
by alternative base transversions (T to either G or A). These
observations support the interpretation that the sharing of
four consecutive mutations by three independently derived
antibodies is more likely due to the influences of selection
than to an extreme bias (62) in the mutation mechanism.
This interpretation is further supported by the differences in
nucleotide sequence between 45-49 and 91A3: histidine 59
replacements occurred by alternative base substitutions, and
a silent nucleotide substitution distinguishes their tyrosine
57 codons.
The seemingly improbable isolation of multiple parallel
somatic alterations can and does occur as shown here for three
antibodies derived from different laboratories. Although the
analyses and observations cited above provide significant evi-
dence against recombinational involvement in somatic alter-
ation, we cannot rule out the possibility that very short donor
segments (<15 bp) generated the somatic alterations. Rather,
the main conclusion of this report is that the observed blocks
ofshared somatic alterations cannot be explained as the prod-
ucts ofone or two direct recombinational (conversion) events
involving genomic sequences; the shared somatic alterations
are apparently the products of multiple independent events.
We interpret this as an indication that an intense selection
pressure has fixed the parallel changes in the three antibodies.
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